Gastro-oesophageal Reflux Disease Trial, Recruiting NCT06757296 Sponsor: Singapore Health Services Condition: Gastro-oesophageal Reflux Disease
Back to Gord

Gastro-oesophageal Reflux Disease Trial, Recruiting

NCT06757296
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 21 and 65 years old
  • People who are scheduled to have a laparoscopic sleeve gastrectomy (a type of weight-loss stomach surgery) at one of the participating hospitals
  • People who are able to understand and agree to take part by signing a consent form

Who may not be able to join:

  • People who are currently pregnant or breastfeeding
  • People who have a severe mental health condition
  • People who have an eating disorder
  • People who currently have an active cancer diagnosis
  • People who have advanced, end-stage kidney disease
  • People who have a condition that affects blood clotting or causes excessive bleeding
  • People who have a pacemaker or an implanted heart device (such as a cardiac defibrillator)
  • People who have a significant heart condition, such as a recent heart attack, heart failure, reduced blood flow to the heart, irregular heartbeat (such as atrial fibrillation), or certain abnormal heart rhythm conditions
  • People who have factors that may make it difficult to follow the study requirements, such as dementia, alcohol or substance use issues, a history of missing appointments or not taking medications as directed, or strong objections from close family members
  • People who are taking blood-thinning or anti-clotting medications that cannot be safely paused for the study period (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chin Hong Lim, MD, Singapore General Hospital

Phone: 62223322

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Singapore Health Services
Registry
ClinicalTrials.gov
Start date
3 February 2025
Est. completion
30 August 2026

Where this trial is recruiting

🇸🇬 Singapore

Primary endpoints

Total amount of weight loss

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov